Benzinga | Aug 12, 2021 05:03PM EDT

Relay Therapeutics Q2 EPS $(0.64) Misses $(0.45) Estimate, Sales $844.00K Miss $8.00M Estimate

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.45) by 42.22 percent. The company reported quarterly sales of $844.00 thousand which missed the analyst consensus estimate of $8.00 million by 89.45 percent.